Global Tissue Engineering Market to Reach $26.8 Billion by 2027
Amid the COVID-19 crisis, the global market for Tissue Engineering estimated at US$11 Billion in the year 2020, is projected to reach a revised size of US$26.8 Billion by 2027, growing at a CAGR of 13.5% over the analysis period 2020-2027. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is projected to record a 12.1% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cardiology & Vascular segment is readjusted to a revised 15.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 13.1% CAGR
The Tissue Engineering market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 13.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.7% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.
Cord Blood & Cell Banking Segment to Record 14.7% CAGR
In the global Cord Blood & Cell Banking segment, USA, Canada, Japan, China and Europe will drive the 14.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.2 Billion by the year 2027.
Select Competitors (Total 33 Featured):
Amid the COVID-19 crisis, the global market for Tissue Engineering estimated at US$11 Billion in the year 2020, is projected to reach a revised size of US$26.8 Billion by 2027, growing at a CAGR of 13.5% over the analysis period 2020-2027. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is projected to record a 12.1% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cardiology & Vascular segment is readjusted to a revised 15.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 13.1% CAGR
The Tissue Engineering market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 13.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.7% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.
Cord Blood & Cell Banking Segment to Record 14.7% CAGR
In the global Cord Blood & Cell Banking segment, USA, Canada, Japan, China and Europe will drive the 14.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.2 Billion by the year 2027.
Select Competitors (Total 33 Featured):
- Acelity L.P. Inc.
- Advanced Cell Technology
- Allergan Plc
- Arteriocyte
- Athersys
- Baxter International Inc
- BioMimetic Therapeutics
- Cook Biotech Inc.
- CryoLife
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- Integra Life Sciences Corporation
- LifeCell Kinetic Concepts
- Medtronic
- Organogenesis Inc.
- RTI surgical
- Sanofi
- StemCells, Inc.
- Stryker Corporation
- Zimmer Biomet
Frequently Asked Questions about the Global Market for Tissue Engineering
What is the estimated value of the Global Market for Tissue Engineering?
What is the growth rate of the Global Market for Tissue Engineering?
What is the forecasted size of the Global Market for Tissue Engineering?
Who are the key companies in the Global Market for Tissue Engineering?
| Report Attribute | Details |
|---|---|
| Published | April 2021 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD ) in 2020 | $ 11 Billion |
| Forecasted Market Value ( USD ) by 2027 | $ 26.8 Billion |
| Compound Annual Growth Rate | 13.6% |
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Companies Mentioned
A selection of companies mentioned in this report includes:
- Acelity L.P. Inc.
- Advanced Cell Technology
- Allergan Plc
- Arteriocyte
- Athersys
- Baxter International Inc
- BioMimetic Therapeutics
- Cook Biotech Inc.
- CryoLife
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- Integra Life Sciences Corporation
- LifeCell Kinetic Concepts
- Medtronic
- Organogenesis Inc.
- RTI surgical
- Sanofi
- StemCells, Inc.
- Stryker Corporation
- Zimmer Biomet
